CPHI -2025 年可持续发展报告 负责任的制药领导策略 Sustainability Report 2025 Strategies for responsible pharma leadership

SustainabilityReport2025:

Strategiesforresponsiblepharmaleadership

Anindepthreviewofthestateofthemostpressingconcernsinthepharmaceuticalindustryregardingsustainability

today,alongwithexpertinsightshowcasingactionableplansonhowcompanieshavetackledthem.

Con

tents

07

11

19

Introduction

Chapterone:Howareinvolved

partiescommunicatingabout

sustainability?

Chaptertwo:Collaboration

....ondatasharingpractices

…onwasteandrecycling

28

32

39

44

Chapterthree:Regulatinga

rapidlychangingindustry

Chapterfour:Howcansustainability

createapre-competitiveadvantage

andboostyourbusiness?

Chapterfive:Howdoesthe

pharmaceuticalindustrycompareto

othersectors?

Chaptersix:CPHIFrankfurt

exclusive–Sustainability

Roundtablediscussion

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership2

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership3

Contents

Introduction

ForewordbyPeylinaChu.

Anindepthreviewofthestateof

themostpressingconcernsinthe

pharmaceuticalindustryregarding

sustainabilitytoday,alongwithexpertinsightshowcasingactionableplansonhowcompanieshavetackledthem.

Chapterone:

Howareinvolvedparties

communicatingabout

sustainability?

Thischapterwillcoverhowcompanies

aretalkingaboutsustainabilityinternally,themessagingthattheyaretryingtogetacrossandhowthisfeedsintothecultureofacompany,andleadsintotheexternalvisionandcommunication,whichcan

extendtomarketingcampaigns.

Wellalsolookatthecommunication

betweenplayersinthefield,how

differentcompaniesinthesupplychaincommunicateaboutsustainabilityandtheimportanceputonthis.Theuseof

consortiumsandothergroupstofurtherthesustainabilitymessaging.Also

communicationwithexternalbodies,

suchasgovernmentandpolicymakers,intheadventofchange.

Chaptertwo:

Collaboration

...ondatasharingpractices

Howcompaniesareworkingtogethertoimprovedatasharingpractices,

encouragemoredatacollectionand

sharing,andthebuildingofmoresuitableplatformssothatthisinformationcanbeshared.

onwasteandrecycling

Howarepharmacompaniesworkingwithexternalbusinessestoimprovewaste

managementandregulationandrecyclingpractices,andhowwillthishelpthe

pharmaceuticalindustrytoovercomeoneofitsbiggestenvironmentalchallenges.

Chapterthree:

Regulatingarapidly

changingindustry

Comparedtootherindustries,regulationaroundsustainabilityinpharmaismuchlessdeveloped.Thisisdueinparttothenatureoftheindustrywithsafetyand

effectivenessbeinghigherprioritiesandalsocomplicatingthematter.

Thereisalsothechallengessurroundingwhoisleadingthechangehere,whetheritcomesfromconsumers,companies,

suppliers,government,healthcare

providersthereisnoclearleader

todrivethisforward.Decisiveaction

needstobetakenbykeyleaderstohelpmomentumforwardinregulation.

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership4

Contents

Chapterfour:

Howcansustainability

createapre-competitive

advantageandboost

yourbusiness?

Pre-emptingsustainabilitychangesin

thefutureandsettingoutyourownsetofguidelinesnotonlyhelpstheplanet

butalsogivesabusinessadvantagebysecuringthecompanyasaheadintheindustry.Thisensuresthatthecompanyismorepreparedinthefaceoffuture

regulationsasalotoftheworkwillhavealreadybeendone.Thisgivesafinancialadvantageasmanysustainable

practicesleadtolongtermreductionincosts,overheadsandincreasedprofitmargins.

Chapterfive:Howdoes

thepharmaceutical

industrycompareto

othersectors?

Thischapterexploresinsightsfromothersectors,suchasthefoodandenergy

industries,whichhaveencountered

similarpressuresanddevisedinnovativesolutions.Byanalysinghowthese

industrieshaveaddressedsustainabilitychallenges,thepharmaceuticalsector

canuncovervaluablemodels,strategies,andpotentialpitfallstoguideitsown

approach.

Chaptersix:

CPHIFrankfurtexclusive–SustainabilityRoundtablediscussion

AtCPHIFrankfurt,heldfrom28–30

October2025attheMesseFrankfurt,

Germany,theinauguralSustainabilityRoundtablewasheld.Organisedby

theCPHISustainabilityCollective,the

roundtableaimedtobringtogether

experts,takingadvantageoftheglobalstageCPHIprovides(andco-opting

thetravelarrangements)todiscusstheactioningofsustainabilitygoalsacrosstheindustry.

Foreword

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership5

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership6

WelcometotheannualSustainabilityReportfromCPHIOnlineonthestateofsustainabilityinthepharmaceuticalindustry.

Likemanyotherindustries,thepharmaceuticalindustryis

facinggreaterandgreaterchallengeseveryday.Geopoliticaltensions,disruptionsinglobaltrade,andpersistentpressurestomakemedicinesmoreaffordablecontinuetotesttheresilienceofourglobalhealthecosystem.Yet,amidthesechallenges,

Iamdeeplyencouragedbytheindustry’sunwavering

commitmenttosustainabilityineverysenseoftheword.

Sustainabilityisnotjustanethicalimperative;itisastrategic

one.Therecognitionthatsustainablepracticesbuildmore

resilientbusinesseshasbecomeundeniable.Thesepractices

arecreatingstrongersupplychains,moreengagedemployees,reducedcosts,andmarket-differentiatingproducts,alldrivingustowardonesharedoutcome–ahealthier,moresustainableworld.

Thisyear,weproudlycelebratethefirstanniversaryofthe

CPHI

SustainabilityCollective

.Injusttwelvemonths,theCollective

hascultivatedextraordinarymomentum,unitingindividuals,

companies,andindustrycollaborativesunderasharedmission

–toaccelerateandamplifysustainabilityprogressacrossthe

globalpharmaceuticallandscape.CPHI’sdeepexperiencein

connectingbusinessesandfosteringpartnershipshasbecome

thefoundationfortranslatingthatsamecollaborationand

innovationintomeaningful,measurablesustainabilityimpact.

The2025CPHISustainabilityReportcelebratestheprogresswehavemadewhileacknowledgingtheworkthatliesahead.IthighlightshowCPHI,theCollective,andourpartnersacrossthepharmaceuticalindustryareunitedinbuildingamore

equitable,regenerative,andhealthierfutureforall.

Recognisingthecontinuedworkahead,wethankyouforyourcontinuedpartnershipandcommitmenttodrivingthisvitaltransformation.

Sincerely,

PeylinaChu

Chair,SteeringCommittee

CPHISustainabilityCollective

Introduction

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership7

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership8

Introduction

Sustainabilityhasbecomeanincreasinglycritical

concernacrossindustries,andthepharmaceuticalsectorisnoexception.Onceviewedprimarilythroughthelens

ofdrugdiscovery,manufacturing,anddistribution,theindustryisnowundergrowingpressuretoconsiderthebroaderenvironmental,social,andeconomicimpactsofitsoperations.Risingexpectationsfromgovernments,investors,patients,andthepublicarepushing

pharmaceuticalcompaniestointegratesustainabilitynotonlyintocomplianceandreporting,butalsointo

theircorebusinessmodels.Againstthisbackdrop,the

pharmaceuticalindustryfacesuniquechallenges:energy-intensiveproductionprocesses,complexglobalsupply

chains,stringentregulatoryframeworks,andalegacyofhighwasteoutput.

InarecentsurveyconductedbyCPHI,individualswere

askedwhatthemainblockorchallengeintheirroleiswhenitcomestoenactingsustainablepractices.Inresponse,

manyindividualspointedtothecostofsustainable

productsandthereluctanceofcustomerstoinvestin

genuinesolutions,oftenfallinginthetrapofgreenwashingratherthanenactingmeaningfulchange.Scope3emissionsandtheavailabilityofaccuratedataforrawmaterialswerealsoconsideredsignificanthurdles,alongsidecompeting

prioritiesandunclearlinkstoROI.Regulatorychallenges,includingongoingchanges,competingtimelines,and

undefinedrequirements,werefrequentlymentioned,as

Introduction

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership9

wastheslowpaceofchangeduetoframeworkslikeGxP.

Additionally,internalcoordination,externalpressures,andthelackofstrongdriversforrenewableenergyadoption

werenoted,compoundedbylimitedgovernmentand

politicalwill.Somerespondentsalsoemphasisedthe

difficultyofbalancingtechnicalcredentials,suchasethicalsourcingandwasteminimisation,witheffectivemarketingthatavoidsoversimplificationoroverpromising.

Althoughmanyofthechallengesweremutuallyfeltandalsocoveredabroadrangeofareas,whichindicatesa

longwaytogofortheindustrytobeindeniablyontrack

whenitcomestomanagingsustainabilitygoals.Yetthesechallengesalsopresentopportunitiesforcollaboration,

innovation,andleadershipinshapingamoresustainablefuture.

Thecurrentpoliticalclimate,particularlyintheUnited

States,hasasignificantinfluenceonthepharmaceutical

industry’ssustainabilityagenda.Policyshiftsunderdifferentadministrationshavebeenshowntoreshapepriorities

forcompaniesovernight,fromdrugpricingreformand

internationaltradetoenvironmentalprotections[1].For

instance,theTrumpadministration’stradetariffsdisruptedglobalsupplychains,increasingcostsforrawmaterialsandactivepharmaceuticalingredients.Furtherderegulationofenvironmentallawshavereducedcompliancepressures

intheshorttermbutheightenedreputationalrisksfor

companiesseekingtopositionthemselvesassustainabilityleaders,andthisultimatelyaddstofurtherdamageto

theplanet.Thedebatearounddrugpricingcontinuesto

dominateUSpolitics,withimplicationsforprofitability,

access,andinvestmentinlong-termsustainability

initiatives.Inanindustrysoreliantonstableregulationandpredictablemarkets,politicalvolatilityamplifiesuncertainty.Thismayinadvertentlyleadtosustainabilitystrategies

beingdeprioritisedduetotheirincreasedcomplexity,butinreality,thesestrategiesarenowevenmorecriticalforresilienceandlong-termstability.

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership10

Thisreportexploressustainabilityinthepharmaceutical

industrythroughfiveinterconnectedperspectives.First,

thereportconsiderstheimportanceofcommunication;

bothinternal,inaligningemployeesandoperationswith

sustainabilitytargets,andexternal,inbuildingtrustwith

regulators,investors,andpatients.Clear,transparent

communicationhasbecomeessentialtodemonstrating

credibilityandcommitment.Second,itexaminestherole

ofcollaborations,consortia,andcross-sectorpartnershipsinadvancingsharedgoals,specificallyindatasharingandwastemanagement.

Regulationisadefiningfeatureofthepharmaceutical

industryandplaysadualroleinshapingitssustainability

efforts.Ontheonehand,strictoversightensureshigh

standardsofsafety,quality,andcompliance,whichare

imperativewhenitcomestomakingmedicineandcan

aligncloselywithenvironmentalandsocialgoals.Onthe

otherhand,evolvingregulations–rangingfromcarbon

reportingrequirementsintheEuropeanUniontotighteningwastemanagementdirectivesanddisclosurerules–createnewoperationalandfinancialdemandsoncompanies.Theglobalnatureofpharmaceuticalsupplychainsaddsfurthercomplexity,ascompaniesmustnavigatefragmented

regulatoryframeworksacrossmarketswhileanticipatingfuturechanges.

Thefourthchapterfocusesonisonthebusinesscasefor

sustainability.Whileenvironmentalstewardshipisoften

framedasamoralobligation,companiesareincreasinglyrecognisingthefinancialandstrategicadvantagesof

embeddingsustainabilityintotheiroperations.Fromcostsavingsandriskmanagementtoreputationalbenefitsandlong-termresilience,sustainabilityisemergingasadriverofvaluecreation.

Finally,thereportlooksbeyondpharmaceuticalstodraw

lessonsfromothersectors,includingthefoodandenergyindustries,whichhavefacedcomparablepressuresand

developedinnovativeresponses.Byexamininghowtheseindustrieshavenavigatedsustainabilitychallenges,the

pharmaceuticalsectorcanidentifymodels,strategies,andpitfallstoinformitsownjourney.

Together,thesechaptersaimtoprovideacomprehensiveunderstandingofhowsustainabilityisbeingaddressed

withinthepharmaceuticalindustry,andhowitmightevolveintheyearstocome.

Chapterone:

Howare

involvedparties

communicating

aboutsustainability?

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership11

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership12

Chapter1:Howareinvolvedpartiescommunicatingaboutsustainability?

Communicationaroundsustainabilityisanessentialpartoftheoperationwhenbuildingintegratedandmeaningfulstepsaroundthesubjectinabusiness.

Sustainabilitycantoucheveryaspectofhowacompanyworks,therefore,thecommunicationthatrunsparallel

tothismustbeofasimilarlyhighqualitytoensurethe

fullpotentialismet.Thiscanincludetheconversations

withcustomers,withsuppliersandpartners,aswellasfortheownersandinvestors,andfortheemployees.Good

communicationleadstotransparencyinactions,whichiskeyinahighprofilefieldsuchassustainabilitywithinthepharmaceuticalindustry.Therearesomanyadvantagestohavingclearmessagingaroundsustainability,whetherit’sinthebreakingdownofknowledgesilostobettersharelearnings,inclarityaroundregulationsandguidelines,orwhenitcomesdowntoanindividuallevel,andcanaidinsalesandbrandawareness[2].Eachhaveavitaleffectonthehealthofthebusinessasawhole.

Theheighteningprofileofsustainabilityinthissectorand

othersmeansmorescrutinyisbeingplacedoncompanies,bybanks,investors,governments,partners,andconsumers.Inthepharmaceuticalindustry,sustainablepracticesare

lessconsumerdriventhaninotherindustries,suchasthefoodorfashionindustry,butmoresofromthosedirectlyinvolvedinthebusinessorfrompartnerships.

Chapter1:Howareinvolvedpartiescommunicatingaboutsustainability?

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership13

Communication,thepartthatsvisible,isonlythetip

oftheiceberg,somuchneedstocomebeforeyousee

sustainabilityrepresentedinacompanysbranding,in

theirESGstrategiesandstatements,intheirexternalandinternalmessaging.Communicationisbackedupby

data,byreportingsystemsandbyactions.Toensurea

companyhasawell-roundedstrategyaboutsustainablecommunication,thereareseveralothermovingparts

thatneedtobeofacertainstandard.Thisisoftenwherecompaniescanfallshortandbeguiltyofgreenwashing,wheretheircommunicationandthenarrativetheyare

feedingisnotsupportedbyreasonableandlong-termaction[2].

Thereareseveralpitfallstoavoidwhenitcomesto

communicatingaboutsustainability,fromgreenwashing,tooverselling,andvagueclaims.Someofthesedont

necessarilyhappenonpurpose,ofcourseacompany

wantstohighlightthethingstheyaredoingwellandare

lessinclinedtohighlightthethingstheyarestrugglingwith,butthisiswherethereneedstobeamindsetshift,asthe

strugglesarejustas,ifnotmoreimportanttoshedlighton,asthisisoftenwherethemostmeaningfulchangesand

thereforethegreatestprogresscanbemade.

Balancingconsistencybetweeninternalsustainabilitymessagingandexternalcommunicationsisessential,particularlywhennavigatingthedelicateequilibrium

Differenttypesofsustainabilitycommunication

Recruitmentadsandjobinterviews

Internalpoliciesandprocedures

Certificationand

ratingsystems

Employeetraininganddevelopment

Reporting

Daily

management

Marketing

communications

Investorrelations

Banking

Socialmedia

Media

appearances-

voluntaryornot

Website

Modifiedfrom[2]

Chapter1:Howareinvolvedpartiescommunicatingaboutsustainability?

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership14

betweencommercialprioritiesandenvironmental

commitments.Companiescanachievethiseffectivelybyfosteringtransparency,aligningtheirstrategieswithclearsustainabilitygoals,andensuringtheirmessagingreflectsboththeirvaluesandactionableprogress.

SandraLopesGuerreiro,GlobalDirectorat

ESTEVE

Healthcare

sharedherthoughts:“Consistencybetween

internalandexternalsustainabilitycommunicationsis

crucial.Thekeyisclarityandprecision:messagesmust

besimple,rigorous,purposeful,andcredible.Bothinternal

teamsandexternalstakeholdersareincreasinglyattentive

towhatcompaniessayandhowtheysayit.

AtESTEVE,ourEHSandCommunicationsdepartmentsworkcloselytoensurealignmentacrossallchannels.Internally,thereisgrowinginterestinsustainability,ashighlightedinourannualpulsesurveys.Weaddressthisthrougharangeofformats,includingTownHalls,departmentalbriefings,

webinars,gamificationinitiatives,andawarenessevents.

Additionally,seniorleadersincludesustainabilitywhen

talkingaboutperformance:sustainabilityKPIsarediscussedinthesamebreathasquality,efficiency,andgrowth.

Externally,weusecorporatesocialmedia,stakeholderengagement(especiallywithcustomersandsuppliers),

andactiveparticipationinindustryassociationsand

conferences.Contributingtotheempowermentofthe

futuregenerations,wesupportschoolsanduniversitiesinsustainabilityeducation,bysharingourexperiencewiththeirstudents.

Ourcommunicationaimstoreflectauthenticity,sharedvalue,andmeasurableprogress.”

Chapter1:Howareinvolvedpartiescommunicatingaboutsustainability?

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership15

Communicationtoensuresmoothenactmentsof

change–nobodylikeschange,butrealisticallythisboils

downtoafearoftheunknown–butifthechangeis

communicatedwell,ifthecontextisgivenandreasoning

behind,thenchangecanbeextremelypositivelyreceived.Thisisespeciallyimportantwithinanorganisationwhere

messagingmustbecommunicatedtoallstakeholders

toensurefullcooperationandalsoallowpeopletovoice

improvementsorfurtherideastofurthertheaimsbehind

saidchanges.Italsogivesspaceforpartiestoensure

alignmentonideas,makingthechangesmoreefficientandbeneficialforall.

NicHunt,GlobalHeadofSustainabilityat

NelipakHealthcare

Packaging

added:

“Sustainabilityinhealthcareinvolvesaddingnew

considerationsintoaregulatedmarket.Thisinvolves

significantchangemanagement.Asacomplex,regulatedsegment,alignmentofallthestakeholdersisarequirement.Alignedcommunication,drivingawarenessandleadingtoconsensusisakeyenablerforsuccessfulchange.”

Itcanbedifficulttothinkoutsidetheboxforhowbestto

communicatethesetopics,especiallywhenworkingwith

severaldifferentstakeholders,whoallrequireaslightly

differentmessageintermsofkeyinformationandpriorities.Huntgaveanexampleofsomecommunicationtacticsthey

utiliseatNelipaktoensureeveryoneintheteamisalignedwiththeirgoals:

“AtNelipakweuseda3-stepapproach–aligntotherecognisedsectorpolestar(UNSDG),set

avision“helphealthcarebesustainable”and

consistentlycommunicatethefocusareasto

deliverthevision–oursustainabilitycircleofsixmostimpactfulthemes.”

NicolaColes,ProgrammeDirectorat

BioPhorum,

addedto

thisbyhelpingdifferentplayerswithinthesupplychainpass

informationinthemostefficientway:

“Understandingwheresupplierstouchanorganisationandensuringthatconsistentmessagesreachtheseteams–notjustprocurementteams–iscriticaltosuccess.”

LopesGuerreiroinputted:

“Thebiggestgame-changerisempoweringfunctional

leadersassustainabilityowners.AtESTEVE,our

procurement,supplychain,engineering,andoperations

leadersareeducatedtounderstandhowsustainabilitylinkstotheirdailydecisions.

Chapter1:Howareinvolvedpartiescommunicatingaboutsustainability?

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership16

Toembedsustainabilitymeaningfully,itiskeytohave

endorsementfromthetopandaclearvisionofwhere

sustainabilitydeliversvalue.Reasonwhywesetshared

cross-functionalbusiness-sustainabilityobjectives,aimingforoperationalexcellence,whilereducingwaste,electricityandwater.Forexample,ourenergyreductiontargetisco-ownedbyEHSandEngineering,Scope3byProcurement

andsoon.Wealsosupportthemincapabilitybuilding,offeringguidanceandtemplatesfordatareporting.

Whensustainabilitybecomesashared

language,consistencyfollows.AtESTEVE,our

commitmenttoreducingourcarbonfootprint

by30%by2030isembeddedinaNetZeroPolicyendorsedbyourCEO,ensuringalignmentfromleadershiptooperations.Atthesametime,it

isextremelyimportantthatwestayflexible

andagiletosupportourcustomers,inatimelymanner,ontheirsustainabilityjourney.”

Frameworksareavaluablewaytoenhance

communication,byfollowingasetmethodology,youcanensurethatyoursustainabilityresultsaredivulgedina

clearmanner,andlesslikelytofallintoanyofthetrapsthatleadtogreenwashingandothermisinformation.

Firstly,havingdatatobackupanyclaimsorinitiativesiskey.Thisdemonstrateswhycertainactionsmayneed

tobetaken,informingoncontext,andaddsalayerofreliabilityandtrusttothebusiness.

Beawarethatsustainabilityforsomecompaniescanbesubjectiveintermsofwhatisapriority,orinhowtoactionthings,soassumptionsaboutthiscanbeharmful,whatisbestforonecompany,mightnotbethesameforanother.

Certificationsandthird-partyassessmentsbringalevelofformalityandtrusttoabusiness.Theseareoftenrigorous

andunbiasedformsofdeterminingthesustainabilityofa

projectorabusiness,whichcanbethenadvertisedasa

measureoftrust.Itisworthnotingthatmostassessmentsarenotuniversalandhavealimittotheparametersthat

theytakeintoaccount,sothecontextoftheseassessmentsareequallyasimportantastheendresults.

“PSCIactsasacatalysisforsustainabilitycommunication,byprovidingacommonconsistentframework,shared

resourcesandaplatformforcollaborationforitsmembersandsuppliers,thatbenefitsthepharmasupplychain.The

PSCI’sPrinciplesforResponsibleSupplyChainManagementserveasafoundationaldocumentthatmembercompaniesintegrateintotheirownsupplierprogrammes.Inthe

pharmaceuticalindustry,wherepatientsafetyandsupplychainintegrityareparamount,anyperceiveddishonestyorlackofcommitmenttoethicalstandardscanhavesevereconsequences.ThePSCIprovidesaframeworktomanage

Chapter1:Howareinvolvedpartiescommunicatingaboutsustainability?

SustainabilityReport2025:Strategiesforresponsiblepharmaleadership17

andmitigatetheserisksbyestablishingclear,sharedexpectations.”–DierdreO’Reilly,PastChairofthe

PSCI,PharmaceuticalSupplyChainInitiative.

Transparencyisanimperativepartofcommunication

aroundsustainabilityandenvironmentalmatters,and

inturn,educatesandencouragesotherstomakemore

sustainablechoices.Withincreasingscrutinyfrominvestors,regulatorsandconsumers,communicationhas